As a first step, we created a Clinical Trials Data Valuation Model in YDC (Figure 1). The model will be based on 10,000 Monte Carlo simulations.The model has the following input variables:

A. Cost of Phase III Oncology Clinical Trial

B. Probability of success of Phase III Oncology Clinical Trial

C. Annual Revenues for Oncology Drug Year 10

D. Gross Margin Percent for Oncology Drugs

E. Gross Margin Year 10 (C x D)

F. Net Present Value (NPV) of Gross Margin over 10 years at 5% Discount (based on E)

G. Expected Value of Clinical Trial [(B x F) – A]

The model has the following output variables:

H. Expected Value of Clinical Trial – Mean

I. Expected Value of Clinical Trial – Max

J. Expected Value of Clinical Trial – Min